Back to results
US 2004/0082553 A1Published application
Novel florfenicol-type antibiotics
AssigneeSchering-Plough Animal Health Corporation
InventorsConstantine G. Boojamra, Lee S. Chong, Scott J. Hecker, Tomasz W. Glinka, Dale E. Shuster
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel florfenicol compounds having the chemical structure: 1 wherein the compounds are useful for the treatment and/or prevention of bacterial infections in a broad range of patients such as, without limitation, birds, fish, shellfish and mammals.
Claims25
A compound having the chemical formula:
- 319
- wherein:
- R1 is selected from the group consisting of —OH and —F;
- R2 and R3 are independently selected from the group consisting of hydrogen, (1C-4C)alkyl, halo, —CF3, —NH2, —CN and N3;
- R4 is selected from the group consisting of:
- —C(═R5)R6,
- wherein:
- R5 is selected from the group consisting of oxygen, N—C≡N, and NOR7,
- wherein:
- R7 is selected from the group consisting of hydrogen, alkyl, aryl, heteroaryl, alicyclic and heteroalicyclic;
- R6 is selected from the group consisting of hydrogen, (1C-4C)alkyl, (3C-6C)cycloalkyl, (1C-4C)alkoxy, heteroaryl, alicyclic and heteroalicyclic;
- 320
- wherein:
- A1 is carbon or nitrogen;
- A2, A3, A4 and A5 are independently selected from the group consisting of carbon, nitrogen, oxygen and sulfur, provided that at least one of A1-A5 is not carbon, that the total number of nitrogen, oxygen and sulfur atoms in the ring does not exceed 4 and that the ring is aromatic;
- carbon atoms in the ring are independently substituted with an entity selected from the group consisting of hydrogen, (1C-4C)alkyl, (3C-6C)cycloalkyl, (1C-4C)alkylO—, —CF3, —OH, —CN, halo, (1C-4C)alkylS(O)—, (1C-4C)alkylS(O)2—, NH2SO2—, (1C-4C)alkylNHSO2—, ((1C-4C)alkyl)2NSO2—, —NH2, (1C-4C)alkylNH—, ((1C-4C)alkyl)2N—, (1C-4C)alkylSO2NH—, (1C-4C)alkylC(O)—, (3C-6C)cycloalkylC(O)—, (1C-4C)alkylOC(O)—, (1C-4C)alkylC(O)NH—, —C(O)NH2, (1C-4C)alkylNHC(O)— and ((1C-4C)alkyl)2NC(O)—, wherein any of the alkyl groups in any of the substituents may be unsubstituted or substituted with a group selected from halo and —OH;
- if A1 is carbon and the ring does not contain oxygen or sulfur, one of the nitrogen atoms may optionally be substituted with an entity selected from the group consisting of (1C-4C)alkyl, (1C-4C)alkylS(O)2— and —NH2;
- 321
- wherein:
- A6, A7, A8, A9 and A10 are independently selected from the group consisting of carbon, nitrogen and
- 322
- provided that only one of A6-A10 at a time can be
- 323
- carbon atoms in the ring are independently substituted with an entity selected from the group consisting of hydrogen, (1C-4C)alkyl, (3C-6C)cycloalkyl, (1C-4C)alkylO—, —CF3, —OH, —CN, halo, (1C-4C)alkylS(O)—, (1C-4C)alkylS(O)2—, NH2SO2—, (1C-4C)alkylNHSO2—, ((1C-4C)alkyl)2NSO2—, —NH2, (1C-4C)alkylNH—, ((1C-4C)alkyl)2N—, (1C-4C)alkylSO2NH—, (1C-4C)alkylC(O)—, (3C-6C)cycloalkylC(O)—, (1C-4C)alkylOC(O)—, (1C-4C)alkylC(O)NH—, —C(O)NH2, (1C-4C)alkylNHC(O)—, ((1C-4C)alkyl)2NC(O)— and —OCH2O—, the oxygen atoms of the —OCH2O— group being bonded to adjacent ring carbon atoms, and wherein any of the alkyl groups in any substituent may be unsubstituted or substituted with a group selected from halo and —OH;
- R8 is hydrogen in all compounds, except when R2 and R3 are both F, in which case R8 is hydrogen or F;
- and,
- the compound is either a racemate having the relative stereochemistry shown or is substantially enantiomerically pure and has the absolute stereochemistry shown.
24 more elements
Dependencies are inferred from the claim text.